Exclusive articles:
BCLI: FDA Meeting Provides Clear Path for Planned Phase 3b Trial of NurOwn
By David Bautz, PhD
NASDAQ:BCLI
READ THE FULL BCLI RESEARCH REPORT
Business Update
Clear Path Forward for Phase 3b Trial of NurOwn
On December 7, 2023, BrainStorm Cell Therapeutics,...
CVM: NICE To Have Your Support
By John Vandermosten, CFA
NYSE:CVM
READ THE FULL CVM RESEARCH REPORT
Multikine Selected as Potential New Standard of Care
CEL-SCI Corporation (NYSE:CVM) provided a pleasant surprise earlier this...
3 Reasons Why META Stock Will Stay a Winner in 2024
Over the past twelve months, shares in Meta Platforms (NASDAQ:META) have more than tripled in price. After such outsized performance, the question now is...
Gen Z Growth Picks: 3 Stocks Capturing the Next Generation’s Attention
While the past several years have focused on the whims and desires of millennials, it’s time to shift this paradigm by focusing largely on...
PROC Stock Earnings: Procaps Gr Beats EPS, Beats Revenue for Q3 2023
Procaps Gr (NASDAQ:PROC) just reported results for the third quarter of 2023.
Procaps Gr reported earnings per share of 8 cents. This was above the...
